Comprehensive Cell Solutions (CCS), part of New York Blood Center Enterprises, is a cell and gene therapy development and manufacturing organization. CCS offers vital capacity to early-stage developers and expertise for hospitals and pharma. Providing a vein-to-vein solution, CCS handles fresh cell collections, cord blood, isolation, manipulation, and cryopreservation from preclinical to commercial stages. Their diverse clientele includes leading pharmaceutical, biotech, and academic institutions. Headquartered in New York, CCS also conducts cellular collections and clinical apheresis there. Visit our website to learn more and connect with us!